Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLX - US1890541097 - Common Stock

107.58 USD
+0.71 (+0.66%)
Last: 11/26/2025, 2:14:57 PM
Fundamental Rating

4

Taking everything into account, CLX scores 4 out of 10 in our fundamental rating. CLX was compared to 12 industry peers in the Household Products industry. While CLX is still in line with the averages on profitability rating, there are concerns on its financial health. CLX is valied quite expensively at the moment, while it does show a decent growth rate. Finally CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CLX had positive earnings in the past year.
CLX had a positive operating cash flow in the past year.
CLX had positive earnings in each of the past 5 years.
Each year in the past 5 years CLX had a positive operating cash flow.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

CLX has a better Return On Assets (14.31%) than 83.33% of its industry peers.
CLX's Return On Invested Capital of 21.90% is fine compared to the rest of the industry. CLX outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 14.85%.
The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 11.68%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CLX's Profit Margin has declined in the last couple of years.
CLX has a Operating Margin of 15.17%. This is comparable to the rest of the industry: CLX outperforms 50.00% of its industry peers.
CLX's Operating Margin has declined in the last couple of years.
The Gross Margin of CLX (44.28%) is better than 66.67% of its industry peers.
CLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLX is creating value.
CLX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CLX has been reduced compared to 5 years ago.
The debt/assets ratio for CLX is higher compared to a year ago.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

CLX has an Altman-Z score of 3.18. This indicates that CLX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLX (3.18) is comparable to the rest of the industry.
The Debt to FCF ratio of CLX is 4.25, which is a neutral value as it means it would take CLX, 4.25 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 4.25, CLX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.18
ROIC/WACC2.83
WACC7.74%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CLX has a Current Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.76, CLX is doing worse than 83.33% of the companies in the same industry.
A Quick Ratio of 0.50 indicates that CLX may have some problems paying its short term obligations.
The Quick ratio of CLX (0.50) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The earnings per share for CLX have decreased strongly by -10.99% in the last year.
Measured over the past 5 years, CLX shows a small growth in Earnings Per Share. The EPS has been growing by 1.01% on average per year.
CLX shows a decrease in Revenue. In the last year, the revenue decreased by -9.35%.
CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.11% yearly.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

Based on estimates for the next years, CLX will show a small growth in Earnings Per Share. The EPS will grow by 2.83% on average per year.
CLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.40% yearly.
EPS Next Y-22.2%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
EPS Next 5Y2.83%
Revenue Next Year-7.81%
Revenue Next 2Y-1.89%
Revenue Next 3Y-0.24%
Revenue Next 5Y1.4%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.01, CLX is valued correctly.
CLX's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.98, CLX is valued a bit cheaper.
With a Price/Forward Earnings ratio of 15.68, CLX is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLX is on the same level as its industry peers.
CLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.01
Fwd PE 15.68
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CLX's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CLX is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 20.6
EV/EBITDA 12.29
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

CLX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.8
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%

7

5. Dividend

5.1 Amount

CLX has a Yearly Dividend Yield of 4.96%, which is a nice return.
Compared to an average industry Dividend Yield of 3.39, CLX pays a better dividend. On top of this CLX pays more dividend than 91.67% of the companies listed in the same industry.
CLX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.96%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has been paying a dividend for at least 10 years, so it has a reliable track record.
CLX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

76.11% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
CLX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (11/26/2025, 2:14:57 PM)

107.58

+0.71 (+0.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners91%
Inst Owner Change-3.75%
Ins Owners0.24%
Ins Owner Change13.55%
Market Cap13.10B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target131.24 (21.99%)
Short Float %5.44%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 4.96%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date10-22 2025-10-22 (1.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-6.45%
PT rev (3m)-7.08%
EPS NQ rev (1m)-3.76%
EPS NQ rev (3m)-6.14%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 16.01
Fwd PE 15.68
P/S 1.93
P/FCF 20.6
P/OCF 15.36
P/B N/A
P/tB N/A
EV/EBITDA 12.29
EPS(TTM)6.72
EY6.25%
EPS(NY)6.86
Fwd EY6.38%
FCF(TTM)5.22
FCFY4.85%
OCF(TTM)7.01
OCFY6.51%
SpS55.6
BVpS-0.18
TBVpS-14.86
PEG (NY)N/A
PEG (5Y)15.8
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.18
F-Score6
WACC7.74%
ROIC/WACC2.83
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.2%
EPS Next 2Y-5.8%
EPS Next 3Y-1.93%
EPS Next 5Y2.83%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.81%
Revenue Next 2Y-1.89%
Revenue Next 3Y-0.24%
Revenue Next 5Y1.4%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year6.95%
EBIT Next 3Y6.71%
EBIT Next 5Y6.75%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CLX.


What is the valuation status of CLOROX COMPANY (CLX) stock?

ChartMill assigns a valuation rating of 3 / 10 to CLOROX COMPANY (CLX). This can be considered as Overvalued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CLOROX COMPANY?

The Earnings per Share (EPS) of CLOROX COMPANY (CLX) is expected to decline by -22.2% in the next year.


Is the dividend of CLOROX COMPANY sustainable?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.